Absence of viral rebound after treatment of HIV-infected patients with didanosine and hydroxycarbamide
- 1 August 1997
- journal article
- Published by Elsevier in The Lancet
- Vol. 350 (9078), 635-636
- https://doi.org/10.1016/s0140-6736(97)24035-3
Abstract
No abstract availableThis publication has 4 references indexed in Scilit:
- Decay characteristics of HIV-1-infected compartments during combination therapyNature, 1997
- 1–year follow-up of the use of hydroxycarbamide and didanosine in HIV infectionThe Lancet, 1996
- Synergistic anti-human immunodeficiency virus type 1 effect of hydroxamate compounds with 2',3'-dideoxyinosine in infected resting human lymphocytes.Proceedings of the National Academy of Sciences, 1994
- Hydroxyurea as an Inhibitor of Human Immunodeficiency Virus-Type 1 ReplicationScience, 1994